Abion Expects Remaining Contract Payment by Nov. 30

• Abion clarified in an October 30, 2026, correction that all deliveries under its research contract were complete.
• Payments received totaled 70% of the contract value; the balance is due by November 30, 2026.
• The KRW 1.74 billion contract with the Agency for Defense Development covers antibody detoxification platform research and development.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abion Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261030900307), on October 30, 2026, and is solely responsible for the information contained therein.